Literature DB >> 22661042

Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Massimo Imazio1, Yehuda Adler.   

Abstract

Empiric anti-inflammatory therapy for acute and recurrent pericarditis is warranted for viral and idiopathic cases that represent most cases of pericarditis in developed countries. For specific uncomplicated etiologies, such as systemic autoimmune diseases and postpericardiotomy syndromes, the same drugs are also indicated. Aspirin and non-steroidal anti-inflammatory drugs (NSAID) are mainstay of therapy with the possible adjunct of colchicine, especially for recurrences. Corticosteroids are a second choice for difficult cases requiring multi-drug therapies and specific medical conditions (i.e., specific cases with systemic autoimmune diseases, postpericardiotomy syndrome, and pregnancy). Medical therapy of pericarditis should be individualized as much as possible providing the attack dose every 8 h to ensure full daily control of symptoms and till remission and C-reactive protein normalization, and then tapering should be considered. The present paper will review current evidence for the treatment of acute and recurrent pericarditis with aspirin, NSAID, corticosteroids, and colchicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22661042     DOI: 10.1007/s10741-012-9328-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  36 in total

Review 1.  Colchicine in clinical medicine. A guide for internists.

Authors:  Giuseppe Cocco; David C C Chu; Stefano Pandolfi
Journal:  Eur J Intern Med       Date:  2010-11-05       Impact factor: 4.487

Review 2.  Autoinflammatory diseases and cardiovascular manifestations.

Authors:  Donato Rigante; Luca Cantarini; Massimo Imazio; Orso Maria Lucherini; Emanuela Sacco; Mauro Galeazzi; Maria Giuseppina Brizi; Antonio Brucato
Journal:  Ann Med       Date:  2011-02-01       Impact factor: 4.709

Review 3.  Controversial issues in the management of pericardial diseases.

Authors:  Massimo Imazio; David H Spodick; Antonio Brucato; Rita Trinchero; Yehuda Adler
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

4.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis.

Authors:  A L P Caforio; A Brucato; A Doria; G Brambilla; A Angelini; A Ghirardello; S Bottaro; F Tona; C Betterle; L Daliento; G Thiene; S Iliceto
Journal:  Heart       Date:  2010-05       Impact factor: 5.994

Review 5.  Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis.

Authors:  Massimo Imazio; Antonio Brucato; Bongani M Mayosi; Francesco Giuseppe Derosa; Chiara Lestuzzi; Antonio Macor; Rita Trinchero; David H Spodick; Yehuda Adler
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-10       Impact factor: 2.160

6.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

Review 7.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

Review 8.  Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.

Authors:  Bernhard Maisch; Günther Hufnagel; Susanne Kölsch; Rainer Funck; Annette Richter; Heinz Rupp; Matthias Herzum; Sabine Pankuweit
Journal:  Herz       Date:  2004-09       Impact factor: 1.443

Review 9.  Cardiac manifestations of HIV infection: an African perspective.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

Review 10.  Colchicine update: 2008.

Authors:  Robert A Terkeltaub
Journal:  Semin Arthritis Rheum       Date:  2008-10-29       Impact factor: 5.532

View more
  26 in total

Review 1.  Immortalization protocols used in cell culture models of human breast morphogenesis.

Authors:  T Gudjonsson; R Villadsen; L Rønnov-Jessen; O W Petersen
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

Review 2.  Recurrent Pericarditis: Modern Approach in 2016.

Authors:  Massimo Imazio; Yehuda Adler; Philippe Charron
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 3.  New clinical trials in acute and recurrent pericarditis.

Authors:  Massimo Imazio
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

4.  A Stretchable and Flexible Cardiac Tissue-Electronics Hybrid Enabling Multiple Drug Release, Sensing, and Stimulation.

Authors:  Ron Feiner; Lior Wertheim; Danielle Gazit; Or Kalish; Gal Mishal; Assaf Shapira; Tal Dvir
Journal:  Small       Date:  2019-03-05       Impact factor: 13.281

5.  [Diagnostics and therapy of pericarditis and pericardial effusion].

Authors:  B Maisch; A D Ristić
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

6.  Diagnostic approaches for pericardial effusions : Beyond mere cytopathology.

Authors:  A G Rigopoulos; M Ali; S Sakellaropoulos; M Matiakis; M Teren; M Mammadov; B Ahmadzada; M Noutsias
Journal:  Herz       Date:  2017-12-15       Impact factor: 1.443

Review 7.  New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Authors:  Bo Xu; Serge C Harb; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 8.  Cardiovascular sequelae of radiation therapy.

Authors:  Francesco Santoro; Nicola Tarantino; Pier Luigi Pellegrino; Marica Caivano; Agostino Lopizzo; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Clin Res Cardiol       Date:  2014-05-07       Impact factor: 5.460

Review 9.  Colchicine in addition to conventional therapy for pericarditis recurrence : An update meta-analysis.

Authors:  Y-L Li; S-B Qiao; J-Y Wang; Y-M Chen; J Luo; H-F Zhang
Journal:  Herz       Date:  2016-03-15       Impact factor: 1.443

Review 10.  Recurrent pericarditis: new and emerging therapeutic options.

Authors:  Massimo Imazio; George Lazaros; Antonio Brucato; Fiorenzo Gaita
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.